Hebei Changshan Biochem Pharma (300255) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.021x

Based on the latest financial reports, Hebei Changshan Biochem Pharma (300255) has a cash flow conversion efficiency ratio of -0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-30.86 Million ≈ $-4.52 Million USD) by net assets (CN¥1.48 Billion ≈ $216.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Hebei Changshan Biochem Pharma's balance sheet to measure how much of total assets are equity-financed.

Hebei Changshan Biochem Pharma - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Hebei Changshan Biochem Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300255 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Hebei Changshan Biochem Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hebei Changshan Biochem Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Constellium Nv NYSE:CSTM	0.227x
Xiangcai Co Ltd SHG:600095	-0.002x
Samsung Card Co. Ltd. KO:029780	0.024x
Bill Com Holdings Inc NYSE:BILL	0.027x
Bilfinger SE XETRA:GBF	0.082x
Tango Therapeutics Inc NASDAQ:TNGX	-0.086x
Beijing Shiji Information Technology Co Ltd SHE:002153	0.060x
Zhejiang Wanfeng Auto Wheel Co Ltd SHE:002085	0.006x

Annual Cash Flow Conversion Efficiency for Hebei Changshan Biochem Pharma (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hebei Changshan Biochem Pharma from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 300255 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.54 Billion ≈ $224.73 Million	CN¥56.22 Million ≈ $8.23 Million	0.037x	+95.34%
2023-12-31	CN¥1.80 Billion ≈ $263.35 Million	CN¥33.73 Million ≈ $4.94 Million	0.019x	+1731.13%
2022-12-31	CN¥3.05 Billion ≈ $446.90 Million	CN¥3.13 Million ≈ $457.36K	0.001x	+9.49%
2021-12-31	CN¥3.07 Billion ≈ $449.55 Million	CN¥2.87 Million ≈ $420.19K	0.001x	+101.45%
2020-12-31	CN¥2.85 Billion ≈ $417.52 Million	CN¥-183.58 Million ≈ $-26.86 Million	-0.064x	-201.33%
2019-12-31	CN¥2.72 Billion ≈ $398.35 Million	CN¥-58.13 Million ≈ $-8.51 Million	-0.021x	-118.40%
2018-12-31	CN¥2.52 Billion ≈ $369.20 Million	CN¥292.81 Million ≈ $42.85 Million	0.116x	+74.17%
2017-12-31	CN¥2.44 Billion ≈ $356.37 Million	CN¥162.28 Million ≈ $23.75 Million	0.067x	-11.29%
2016-12-31	CN¥2.29 Billion ≈ $335.01 Million	CN¥171.96 Million ≈ $25.16 Million	0.075x	+409.43%
2015-12-31	CN¥1.57 Billion ≈ $229.92 Million	CN¥-38.14 Million ≈ $-5.58 Million	-0.024x	+59.24%
2014-12-31	CN¥1.43 Billion ≈ $208.80 Million	CN¥-84.97 Million ≈ $-12.43 Million	-0.060x	-402.15%
2013-12-31	CN¥1.29 Billion ≈ $188.11 Million	CN¥-15.24 Million ≈ $-2.23 Million	-0.012x	+81.10%
2012-12-31	CN¥1.13 Billion ≈ $164.72 Million	CN¥-70.62 Million ≈ $-10.33 Million	-0.063x	-463.52%
2011-12-31	CN¥987.45 Million ≈ $144.49 Million	CN¥17.04 Million ≈ $2.49 Million	0.017x	-87.05%
2010-12-31	CN¥219.39 Million ≈ $32.10 Million	CN¥29.25 Million ≈ $4.28 Million	0.133x	-12.34%
2009-12-31	CN¥159.19 Million ≈ $23.30 Million	CN¥24.21 Million ≈ $3.54 Million	0.152x	+146.09%
2008-12-31	CN¥93.43 Million ≈ $13.67 Million	CN¥-30.83 Million ≈ $-4.51 Million	-0.330x	--

About Hebei Changshan Biochem Pharma

SHE:300255 China Biotechnology

Market Cap

$3.39 Billion

CN¥23.17 Billion CNY

Market Cap Rank

#4514 Global

#705 in China

Share Price

CN¥25.21

Change (1 day)

+1.00%

52-Week Range

CN¥21.95 - CN¥69.80

All Time High

CN¥69.80